New Self-Assembling Polymers Proven To Be Effective At Gene Delivery

A collaboration of scientists at the University of Manchester and the University of Birmingham have explored a more effective and less toxic way of delivering genetic material into cells, a challenge central to areas such as gene therapy, biotechnology and genome editing.

This new technique utilises self‑assembling polymer carriers for gene delivery, improving effectiveness and reducing the toxicity to cells over existing techniques in lab tests. These advances rely on safe and efficient methods for delivering gene‑editing tools into cells, which is a key bottleneck in enabling widespread application. Improving upon existing gene delivery methods has become essential to enable these developments and allow more effective transfection.

The process of introducing DNA or RNA into cells to change gene expression, can be achieved using viral or non‑viral vectors. While viral vectors are powerful, they raise safety and manufacturing concerns, driving intense interest in the development of safer, non‑viral alternatives. Transfection, using polymeric carriers or lipid nanoparticles to deliver genetic material, is a key non‑viral strategy. However current systems often struggle to balance efficiency and toxicity. In order to develop polymer systems for molecular delivery applications, more advanced polymer systems need to be developed and screened.

In research published in ACS Materials Letters, the team demonstrates that polyplexes produced via Polymerization‑Induced Electrostatic Self‑Assembly (PIESA) offer a more effective and versatile route to gene delivery than conventional produced polymeric polyplexes. Polyplexes are formed when positively charged polymers bind to negatively charged DNA or RNA, creating nanoscale complexes that can enable genetic material to enter cells. Traditionally, polyplexes are prepared using pre-synthesised polymers which are then mixed with DNA or RNA. However, this post‑assembly step can lead to instability and increased cell toxicity, often limiting the size of genetic payloads that can be delivered effectively.